• P Hanauer, J Slade, D E Barnes, L Bero, and S A Glantz.
• Institute for Health Policy Studies, University of California, San Francisco, USA.
• JAMA. 1995 Jul 19; 274 (3): 234240234-40.

ObjectiveTo understand how attorneys for the tobacco industry in general, and Brown and Williamson Tobacco Corporation (B&W) in particular, have responded to the threat of products liability litigation arising from smoking-induced diseases.Data SourcesDocuments from B&W, the British American Tobacco Company (BAT), and other tobacco interests provided by an anonymous source, obtained from Congress, or received from the private papers of a former BAT officer.Study SelectionAll available materials, including confidential reports regarding research and internal memoranda exchanged between tobacco industry lawyers.ConclusionsThe documents demonstrate that the tobacco industry in general, and B&W in particular, were very concerned about the threat of products liability lawsuits, and they illustrate some of the steps taken by lawyers at one company to avoid the discovery of documents that might be useful to a plaintiff in such a lawsuit. These steps included efforts to control the language of scientific discourse on issues related to smoking and health, to bring all potentially damaging internal scientific documents under attorney work product and attorney-client privilege to avoid discovery, to remove "deadwood" documents, and to insulate B&W from knowledge of potentially damaging scientific information from other BAT companies.

20 keywords...

hide…